Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma

BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy with a multifaceted immune dysfunction. Indoleamine 2,3-dioxygenase 1 (IDO1) degrades tryptophan into kynurenine (KYN), which inhibits effector T cells and promote regulatory T-cell (Treg) differentiation. It is presently unknown whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanno, Giuseppina, Mariotti, Andrea, Procoli, Annabella, Folgiero, Valentina, Natale, Daniela, De Rosa, Luca, Majolino, Ignazio, Novarese, Linda, Rocci, Alberto, Gambella, Manuela, Ciciarello, Marilena, Scambia, Giovanni, Palumbo, Antonio, Locatelli, Franco, De Cristofaro, Raimondo, Rutella, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543251/
https://www.ncbi.nlm.nih.gov/pubmed/23232072
http://dx.doi.org/10.1186/1479-5876-10-247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543251/
https://www.ncbi.nlm.nih.gov/pubmed/23232072
http://dx.doi.org/10.1186/1479-5876-10-247

Ejemplares similares